trial/26580). Data were analyzed in SPSS software version 22.0 using the Chi-square test and Independent T-test.
Results
In this study, 100 women who had referred to Ali ibn-e Abitalib hospital, Zahedan, for missed abortions were evaluated. The mean patient age, the mean number of pregnancies, and the mean gestational age were 28 ± 7 years (minimum 14, maximum 47), 3 ± 2 (minimum 1, maximum 9), and 52 ± 13 (minimum 28, maximum 98) days, respectively.
As shown in Table 1 , 16 out of 50 women in the control group (32%) and 42 out of 50 women (84%) in the case group had successful abortions. Suction curettage was performed on the rest of women to remove pregnancy remnants.
Both groups were also compared in terms of gravidity, gestational age, causes of termination of pregnancy, and Misoprostol dosage (Table 2) .
In terms of gravidity, 25 women were primigravid, while 75 were multigravida. Of the 25 primigravid, 12 women were in the control group and 13 in the case group. Accordingly, out of the 75 multigravida, 38 women belonged to the control group and 37 to the case group. The mean gravidity in the control group was 3 ± 1 (minimum 1 and maximum 9) and in the case group was 3 ± 2 (minimum 1 and maximum 7). There was no significant difference between the two groups in terms of gravidity.
Regarding the causes of termination of pregnancy, 95 women had missed abortions (50 in the control group and 45 in the case group); 4 abortions were blighted ovum, all of which were from the control group; and 1 abortion was induced abortion which belonged to the control group. Moreover, 34 out of the 50 women with missed abortions in the control group did not have successful abortions and so underwent suction curettage. Likewise, 8 out of the 45 women with missed abortions in the case group did not have successful abortions and underwent suction curettage. Accordingly, 4 cases of blighted ovum and one case of induced abortion successfully aborted the product of pregnancy and did not undergo suction curettage.
In terms of the dosage of misoprostol, 84 women received misoprostol 800 µg, from which 39 were in the control group and 45 in the case group. In the control group, 7 women needed a second dose and 4 women required a third dose of misoprostol 800 µg. In the case group, 3 women required a second dose of Misoprostol 800 μg and 2 women needed a third dose of Misoprostol. The mean dose of Misoprostol in the control group (400 ± 1000) and in the case group (900 ± 300) were not significantly different (P = 0.1).
Regarding the gestational age, 44 women were of less than 7 weeks of pregnancy (56 days) and 56 women were of above 7 weeks. Of these, 21 women were pregnant for less than 7 weeks and 29 women were pregnant for more than 7 weeks in the control group. While in the case group, 23 women were pregnant for less than 7 weeks, and 27 women were pregnant for more than 7 weeks. The groups were not significantly different in terms of gestational age.
The mean abortion time in the control group was 5 ± 10 hours and in the case group was 4 ± 8 hours, which showed a significant difference between two groups (P = 0.038).
No significant side effects were recorded for both groups regarding the consumed drug.
Discussion
About 40 million abortions per year, either legal or illegal, occur worldwide, resulting in an abortion rate of up to 3.5% (9, 10) (14, 15) . So far, many studies have been conducted on various types of medical abortion, but few studies have considered the effects of estrogen priming on the success of induction. Therefore, this study aimed to compare the incidence of abortion in the first trimester using misoprostol and misoprostol with estrogen priming. Our study showed that the success rate of medical abortion in the group using misoprostol alone was only 38%, while the success rate in the group using misoprostol with estrogen priming was 86%; the difference was statistically significant (P <0.0001). The results also displayed that the induction-to-abortion time in the case group was significantly lower than that in the control group (P = 0.049). Moreover, no significant difference was observed between the two groups in terms of side effects. In a study conducted by Rudasari et al in Mashhad (2004 Mashhad ( -2006 on 100 pregnant women at their first trimester, the effect of Methotrexate and Misoprostol on the success rate of abortion was investigated. It was found that 81 (81%) of the women had successful medical abortion and 19 women underwent suction curettage (16) .
. Surgical methods including dilatation and curettage (D & C), dilatation and evacuation (D & E), and
In another study by Salari et al conducted in Kerman on 80 women at 13-25 weeks of gestational age, the women were randomly divided into 2 groups receiving either Misoprostol alone or Misoprostol and Laminaria. They reported that time to abortion in the group of misoprostol and Laminaria was significantly shorter than that in the misoprostol alone group and the rate of curettage in the women receiving the combination of two drugs was significantly lower compared to the misoprostol alone group (17) .
In a study by Chawdhary et al in 2009, the effect of mifepristone with vaginal misoprostol and misoprostol alone at a gestational age of 63 days or less for the induction abortion was evaluated. It was found that mifepristone with misoprostol increase the success rate of abortion and decrease the complications (18) .
In a study by Rezai et al in 2014 on pregnant women in the first trimester of pregnancy, the effect of combination of misoprostol and letrozole was compared with misoprostol alone on the termination of pregnancy. It was observed that complete abortion occurred in 174 women (81.3%), from which 84 women (78.5%) were in the misoprostol alone group and 90 women (84.1%) in the combination group. They eventually concluded that misoprostol alone was as effective as the combination of misoprostol and letrozole (19) .
In several other studies, it was seen that the use of estrogen along with other medications significantly increased the success rate of abortion and reduced the time to abortion (20, 21) . Accordingly, the effect of combination of misoprostol with estrogen priming on the success rate of medical abortion and the improvement of complications was confirmed in this study.
Conclusions
The results of this study revealed that the success rate of termination of pregnancy in the first trimester was significantly higher in the estrogen priming and misoprostol group compared to the Misoprostol alone group. Moreover, the time to abortion was lower in the group with the combination of 2 drugs. The costeffectiveness of oral single-dose estradiol and shortening the time to abortion was also confirmed in this study. Furthermore, the women's acceptance was highly desirable. It seems that conducting such studies on a wider population, together with the selection of appropriate approaches could lead to a detailed planning for better health interventions.
Conflict of Interests
Authors declare that they have no conflict of interests.
Ethical Issues
This study was part of a dissertation which was approved by the Ethics Committee of Zahedan University of Medical Sciences in 2016 (Code of Ethics: IR. ZAUMS. REC.1396.9).
Financial Support
No financial support was obtained from any organization or university.
